PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver1–3
- 1 April 2011
- journal article
- Published by Elsevier BV in Journal of Nutrition
- Vol. 141 (4), 603-610
- https://doi.org/10.3945/jn.110.135210
Abstract
Emerging evidence suggests that the lack of PPARα enhances hepatic steatosis and inflammation in Ppara-null mice when fed a high-fat diet (HFD). Thus, the aim of this study was to determine whether Ppara-null mice are more susceptible to nonalcoholic steatohepatitis (NASH) than their wild-type (WT) counterparts following short-term feeding with a HFD. Age-matched male WT and Ppara-null mice were randomly assigned to consume ad libitum a standard Lieber-DeCarli liquid diet (STD) (35% energy from fat) or a HFD (71% energy from fat) for 3 wk. Liver histology, plasma transaminase levels, and indicators of oxidative/nitrosative stress and inflammatory cytokines were evaluated in all groups. Levels of lobular inflammation and the NASH activity score were greater in HFD-exposed Ppara-null mice than in the other 3 groups. Biochemical analysis revealed elevated levels of ethanol-inducible cytochrome P450 2E1 and TNFα accompanied by increased levels of malondialdehyde as well as oxidized and nitrated proteins in Ppara-null mice. Elevated oxidative stress and inflammation were associated with activation of c-Jun-N-terminal kinase and p38 kinase, resulting in increased hepatocyte apoptosis in Ppara-null mice fed a HFD. These results, with increased steatosis, oxidative stress, and inflammation observed in Ppara-null mice fed a HFD, demonstrate that inhibition of PPARα functions may increase susceptibility to high fat–induced NASH.Keywords
This publication has 43 references indexed in Scilit:
- Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient dietEuropean Journal of Pharmacology, 2006
- Increased oxidation and degradation of cytosolic proteins in alcohol‐exposed mouse liver and hepatoma cellsProteomics, 2006
- The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort StudyGastroenterology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signalingFree Radical Biology & Medicine, 2005
- High‐fat diet enhances visceral advanced glycation end products, nuclear O‐Glc‐Nac modification, p38 mitogen‐activated protein kinase activation and apoptosisDiabetes, Obesity and Metabolism, 2004
- Identification of oxidized mitochondrial proteins in alcohol‐exposed human hepatoma cells and mouse liverProteomics, 2004
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*Endocrine Reviews, 1999
- Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in AgingPublished by Elsevier BV ,1998
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998